Search
Find a recruiting study
7,106 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Nov 1, 2026). No sign-up needed.
Most recently updated studies · page 107 of 297
- Recruiting
A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair
Auxilium Biotechnologies
- Location
- San Diego, CA + 7 other US sites
- Eligibility basics
- Ages 18–80
- Recruiting
MultiCenter IDE Study of the PEEK-OPTIMA™ Femoral Component vs a CoCr Alloy TKA Femoral Component of Similar Design
Maxx Orthopedics Inc
- Location
- Leawood, KS + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Atacicept in Multiple Glomerular Diseases
Vera Therapeutics, Inc.
- Location
- Brisbane, CA
- Eligibility basics
- Ages 2+
- RecruitingPhase 3
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
Cerium Pharmaceuticals, Inc.
- Location
- Los Angeles, CA + 18 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Wearable Sensory Prosthesis to Improve Coordination, Walking, and Physical Activity
RxFunction Inc.
- Location
- Jacksonville, FL
- Eligibility basics
- Ages 60+
- Recruiting
Integrity Implant System Post Market Clinical Follow-Up Study
Anika Therapeutics, Inc.
- Location
- Gilbert, AZ + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in…
Apellis Pharmaceuticals, Inc.
- Location
- Gilbert, AZ + 77 other US sites
- Eligibility basics
- Ages 60+
- Recruiting
Establishing the Preliminary Utility of a Novel Pediatric Manual Mobile Standing Wheelchair
Optimal Mobility, Inc
- Location
- Saint Paul, MN
- Eligibility basics
- Ages 8–17
- RecruitingPhase 4
Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management…
Sequence LifeScience, Inc.
- Location
- North Royalton, OH
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Ansun Biopharma, Inc.
- Location
- Duarte, CA + 18 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Novartis Pharmaceuticals
- Location
- Huntsville, AL + 29 other US sites
- Eligibility basics
- Ages 50–80
- RecruitingPhase 2
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
GEn1E Lifesciences
- Location
- Baltimore, MD + 4 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 1
Study of BHV-1400 in IgA Nephropathy
Biohaven Therapeutics Ltd.
- Location
- Farmington, CT + 13 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
Shionogi
- Location
- Irvine, CA + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Bristol-Myers Squibb
- Location
- Bentonville, AR + 19 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)
Amplifi Vascular, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18+
- Recruiting
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
Fisher and Paykel Healthcare
- Location
- Birmingham, AL + 3 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 2
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
Neurocrine Biosciences
- Location
- Bryant, AR + 17 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- Birmingham, AL + 112 other US sites
- Eligibility basics
- Ages 45+
- Recruiting
Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding
Medtronic - MITG
- Location
- New Haven, CT + 5 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
Sanofi
- Location
- Clovis, CA + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta
Amgen
- Location
- Indianapolis, IN
- Eligibility basics
- Ages 5–19
- RecruitingPhase 2
A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
ERX Pharmaceuticals
- Location
- Louisville, KY + 2 other US sites
- Eligibility basics
- Ages 18–60
- Recruiting
Safety, Efficacy and Preventative Effect of a Head Lice Product (X92001483) vs. Nix Creme Rinse (1% Permethrin).
Oystershell NV
- Location
- Maitland, FL
- Eligibility basics
- Ages 1+
Data source: daily sync of the ClinicalTrials.gov API. How we list studies